We processed PBMCs of the entire study population in four different batches. Frozen PBMCs were thawed, washed twice with PBS (Fisher Scientific) and stained with live/dead marker (Zombie Yellow™ Fixable Viability dye, eBioscience) and fluorochrome-conjugated antibodies against surface markers: anti-CD19 BV510, anti-CD24 BV421, anti-IgD APC-Cy7 (all BioLegend); anti-CD27 AF-700, anti-CD38 APC, anti-CD40 PE-Cy7, anti-BAFF-R FITC (all eBioscience); anti-CD86 PE-CF594, and anti-TACI BV650 (all BD Biosciences). A total of five B cell subpopulations could be measured using the following gating strategy as previously reported (18 (link)): total (CD19+), transitional (CD19+CD24hiCD38hi), naïve (CD19+CD27-), unswitched memory (CD19+CD27+IgD+) and switched memory B cells (CD19+CD27+IgD-). We measured expression of CD40, BAFF-R and TACI as percentage of positive cells for all five B cell subsets and as mean of fluorescence intensity (MFI) across positive cells for each cell type. The absolute cell counts of plasmablasts (CD19+CD24-CD38hi) were too low (< 100 cells) to reliably determine expression levels. Data were collected on BD Symphony flow cytometer (BD Biosciences). For data analysis, we used FlowJo (LLC, V10). Supplementary Figure 1 shows representative FACS plots.
Free full text: Click here